acromegaly

Hypersecretion of growth hormone (GH) [5] as the cause of acromegaly is confirmed by measuring serum GH during an oral glucose tolerance test (OGTT).

Acromegaly is a condition predisposing patients to OSP-induced nephropathy.

He didn't say anything to me but told Rob, 'I'm sure he has acromegaly.

Acromegaly associated with monoclonal gammopathy of undetermined significance (MGUS).

Acromegaly is a rare but complex disease of mainly adults aged between 40 to 60 that results in serious physical disfigurement, he added.

There are two different etiologic mechanisms of acromegaly caused by excess GH in MEN-1 with different treatment implications.

Of the five patients with growth hormone excess, one patient had gigantism while the others had acromegaly.

They cover pituitary cell development and organization in adults, genetics, research topics, therapies, tumorigenesis, prolactinomas, growth hormone and acromegaly, the role of estrogens in the remodeling of the anterior pituitary gland, alcohol-induced hyperprolactinemia, gender differences in tumors, carcinomas, testing growth hormone deficiency in adults, imaging, the hypothalamic-pituitary-adrenal axis, Cushing disease, and other topics.

Skin manifestations include coarse facial features reminiscent of acromegaly.

The two shook hands and Dr Britt noticedA Gurrieri's huge, spongy-feeling hand and his large facial features as symptoms of acromegaly, a tumour at the base of the brain.

Brisbane CA) won approval for its medicine, Somatuline Depot, as a treatment option for patients with acromegaly, a condition marked by excessive growth of the head and extremities.

About 20% of pituitary tumors can cause acromegaly (Arafah & Nasrallah, 2001); these tumors produce an excess of GH.

He shot up after reaching the age of 16, and has now beaten the previous natural, and not the result of a condition such as giantism or acromegaly, caused by too much growth hormone.

Novartis, Basel, Switzerland, has announced that the Japanese health authority has approved Sandostatin LAR (octreotide acetate for injectable suspension) for the treatment of acromegaly and pituitary gigantism which is unresponsive to or unsuitable for surgery or other drug therapies, and for symptoms associated with gastrointestinal hormone secreting tumors (also known as gastroenteropancreatic (GEP) neuroendocrine tumors (NET), including carcinoid tumors, gastrinomas, and VIPomas (Vasoactive Intestinal Peptide- secreting tumors).

A ACROMEGALY causes excessive growth of the hands, feet, jaw, face, tongue and internal organs.